Company intelligence / Profile preview

Estar Medical

Ownership: Private
Development stage: Commercial

Overview

Estar Medical’s patented PRP and autologous cell therapy technologies are FDA and CE approved. The company’s products are used globally in multiple medical fields for non-surgical healing treatments. No clinical trial results for drug candidates; the company focuses on device-based regenerative solutions

Therapeutic areas: OtherDermatologyOphthalmologyCardiovascular
Modalities: Platelet-rich plasma therapyAutologous cell therapyBiologic
Industry: Therapeutic Medical Devices

Drug pipeline

4 assets

Tropocells PRP

Commercial

Indications: Multiple medical applications

3 more assets in the full pipeline.

Request access →

Partnerships

Exclusive U.S. distribution agreement with Aesthetic Management Partners for the Cellenis PRP product line

Beyond the preview

Go deeper on Estar Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estar Medical.

Explore the full profile